Lu-Ann Murdoch
ARTICLES BY THIS AUTHOR
- 11/8/2022
POP QUIZ: Obesity in adults
Obesity Canada has released new guidance on pharmacotherapy for obesity management in adults. - 11/2/2022
Proper disposal of medications highlighted in new video and wall poster
Designed to assist pharmacists in educating patients and reinforcing safe medication disposal practices. - 11/1/2022
Tezspire now available for add-on maintenance treatment of severe asthma
First biologic for severe asthma targeting thymic stromal lymphopoietin is effective regardless of phenotype. - 10/27/2022
Breztri Aerosphere now available for long-term maintenance treatment of COPD
Second 'triple-therapy' combination product approved in Canada for COPD maintenance treatment to reduce exacerbations and treat airflow obstruction. - 10/25/2022
POP QUIZ: Anxiety disorders in children
The Canadian Paediatric Society recently released new guidance on the diagnosis and management of anxiety disorders in children and youth. - 10/24/2022
Will angiotensin receptor II blockers play a role in epilepsy prevention?
Study examines whether ARB therapy is associated with a decreased incidence of new onset epilepsy in patients with hypertension. - 10/19/2022
Health Canada approves two therapies for COVID-19 treatment
Single-dose Evusheld is now indicated for treating mild/moderate COVID-19 and Actemra IV is now approved for treating COVID-19 in hospitalized adults. - 10/17/2022
Canadian researchers pinpoint top 9 prescribing cascades in older adults
Lead a multidisciplinary panel to identify clinically important cascades consistent with potentially inappropriate prescribing. - 10/14/2022
POP QUIZ: COVID-19 vaccine booster shots
The National Advisory Committee on Immunization recently released new guidance on COVID-19 booster doses. Are you up to date? Test your knowledge with this pop quiz. - 10/5/2022
Pharmacist email alerts fail to reduce co-prescribing of benzodiazepines and opioids
Study examines whether email alerts sent by pharmacists to prescribers and primary care managers reduce co-prescribing of opioids and benzodiazepines.
